Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis.
暂无分享,去创建一个
E. Vibert | M. Terasawa | A. Saiura | R. Adam | N. Golse | M. Allard | A. Sa cunha | D. Cherqui | Muga Terasawa
[1] K. Kim,et al. Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular Carcinoma , 2011, Annals of Surgical Oncology.
[2] M. Ronot,et al. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[3] V. Vilgrain,et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma , 2006, The British journal of surgery.
[4] Olivier Ernst,et al. Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. , 2007, Journal of the American College of Surgeons.
[5] D. Samuel,et al. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? , 2015, Journal of hepatology.
[6] K. Sung,et al. Ischemic Bile Duct Injury as a Serious Complication After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma , 2001, Journal of clinical gastroenterology.
[7] T. Baumert,et al. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature. , 2016, Minerva chirurgica.
[8] C. Gonçalves,et al. [Hepatocellular carcinoma]. , 1988, Arquivos de gastroenterologia.
[9] R. Lencioni,et al. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data , 2016, Hepatology.
[10] Yanming Zhou,et al. Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma , 2013, BMC Gastroenterology.
[11] Fan Wu,et al. Solitary Large Hepatocellular Carcinoma: A Specific Subtype of Hepatocellular Carcinoma With Good Outcome After Hepatic Resection , 2009, Annals of surgery.
[12] R. Hirose,et al. Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria , 2015, Hepatology.
[13] H. Bismuth,et al. Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver , 2000, Annals of surgery.
[14] V. Vilgrain,et al. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial , 2003, Annals of surgery.
[15] H. Bismuth,et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. , 1997, Annals of surgery.
[16] T. Gamblin,et al. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. , 2015, Surgical oncology clinics of North America.
[17] A. Rademaker,et al. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.
[18] O. Farges,et al. The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.
[19] L. Leong,et al. Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations. , 2009, Gastrointestinal cancer research : GCR.
[20] F. Roudot-thoraval,et al. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.
[21] S. Zangan,et al. Hepatocellular Carcinoma Rupture Following Transarterial Chemoembolization , 2015, Seminars in Interventional Radiology.
[22] E. Benchimol,et al. Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data , 2019, BMC Gastroenterology.
[23] W. Lau,et al. A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.
[24] M. Makuuchi,et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.
[25] M. Schwartz,et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. , 2002, The Lancet. Oncology.
[26] L. Henry,et al. Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up , 2015, Annals of Surgical Oncology.
[27] F. P'eng,et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal , 1995, The British journal of surgery.
[28] H. Hasegawa,et al. A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma , 1996, Japanese journal of cancer research : Gann.